BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3427175)

  • 1. Nonparametric estimation of duration of accrual and total study length for clinical trials.
    Morgan TM
    Biometrics; 1987 Dec; 43(4):903-12. PubMed ID: 3427175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification.
    Lachin JM; Foulkes MA
    Biometrics; 1986 Sep; 42(3):507-19. PubMed ID: 3567285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of additional follow-up and accrual on survival time data.
    Brookmeyer R; Self SG
    Biometrics; 1985 Mar; 41(1):129-36. PubMed ID: 3890978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A note on P-values under group sequential testing and nonproportional hazards.
    Gillen DL; Emerson SS
    Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonparametric estimation of a multivariate distribution in the presence of censoring.
    Hanley JA; Parnes MN
    Biometrics; 1983 Mar; 39(1):129-39. PubMed ID: 6871341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study duration for clinical trials with survival response and early stopping rule.
    Kim K; Tsiatis AA
    Biometrics; 1990 Mar; 46(1):81-92. PubMed ID: 2350572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of accrual and follow-up for two-stage clinical trials.
    Case LD; Morgan TM
    Lifetime Data Anal; 2001 Mar; 7(1):21-37. PubMed ID: 11280845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating equations with incomplete categorical covariates in the Cox model.
    Lipsitz SR; Ibrahim JG
    Biometrics; 1998 Sep; 54(3):1002-13. PubMed ID: 9750248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proportional hazards model taking account of long-term survivors.
    Tsodikov A
    Biometrics; 1998 Dec; 54(4):1508-16. PubMed ID: 9883549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variance estimation in clinical studies with interim sample size re-estimation.
    Miller F
    Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of multi-centre trials with binary response.
    Dragalin V; Fedorov V
    Stat Med; 2006 Aug; 25(16):2701-19. PubMed ID: 16252268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design.
    Markman M; Markman J; Webster K; Zanotti K; Kulp B; Peterson G; Belinson J
    J Clin Oncol; 2004 Aug; 22(15):3120-5. PubMed ID: 15284263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size estimation for the van Elteren test--a stratified Wilcoxon-Mann-Whitney test.
    Zhao YD
    Stat Med; 2006 Aug; 25(15):2675-87. PubMed ID: 16372389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size determination in clinical trials with an emphasis on exponentially distributed responses.
    Gross AJ; Hunt HH; Cantor AB; Clark BC
    Biometrics; 1987 Dec; 43(4):875-83. PubMed ID: 3427172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size estimation for non-inferiority trials of time-to-event data.
    Crisp A; Curtis P
    Pharm Stat; 2008; 7(4):236-44. PubMed ID: 17583558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating maximum power losses in survival studies with nonstratified randomization.
    Palta M
    Biometrics; 1985 Jun; 41(2):497-504. PubMed ID: 4027324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approximate case influence for the proportional hazards regression model with censored data.
    Cain KC; Lange NT
    Biometrics; 1984 Jun; 40(2):493-9. PubMed ID: 6386066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confidence intervals for median survival times under a piecewise exponential model with proportional hazards covariate effects.
    Karrison T
    Stat Med; 1996 Jan; 15(2):171-82. PubMed ID: 8614753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tests of significance using regression models for ordered categorical data.
    Snapinn SM; Small RD
    Biometrics; 1986 Sep; 42(3):583-92. PubMed ID: 3567291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.